Post Publication Amendment

DAXXIFY

Revance Therapeutics, Inc

Post Publication Amendment

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1771 (Rev 10/2011)
OMB No. 0651-0050 (Exp 09/20/2020)

Post-Approval/Publication/Post-Notice of Allowance (NOA) Amendment


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88852845
LAW OFFICE ASSIGNED LAW OFFICE 125
MARK SECTION
MARK mark
LITERAL ELEMENT DAXXIFY
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size or color.
OWNER SECTION (current)
NAME Revance Therapeutics, Inc
MAILING ADDRESS 7555 Gateway Blvd.
CITY Newark
STATE California
ZIP/POSTAL CODE 94560
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
OWNER SECTION (proposed)
NAME Revance Therapeutics, Inc.
MAILING ADDRESS 7555 Gateway Blvd.
CITY Newark
STATE California
ZIP/POSTAL CODE 94560
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
EXPLANATION OF FILING
A typographical error was made in the applicant?s name when the application was filed, specifically, the period at the end of ?Inc? is missing. The applicant?s correct name is ?Revance Therapeutics, Inc.? This error occurred in good faith.
CORRESPONDENCE INFORMATION (current)
NAME MAREN C. PERRY
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE nytrademarks@kslaw.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) mperry@kslaw.com
DOCKET/REFERENCE NUMBER 13720.104073
CORRESPONDENCE INFORMATION (proposed)
NAME Maren C. Perry
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE nytrademarks@kslaw.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) mperry@kslaw.com
DOCKET/REFERENCE NUMBER 13720.104073
SIGNATURE SECTION
RESPONSE SIGNATURE /mcp/
SIGNATORY'S NAME Maren C. Perry
SIGNATORY'S POSITION Attorney of Record, New York Bar member
SIGNATORY'S PHONE NUMBER (212) 556-2128
DATE SIGNED 07/16/2020
AUTHORIZED SIGNATORY YES
FILING INFORMATION SECTION
SUBMIT DATE Thu Jul 16 17:28:03 ET 2020
TEAS STAMP USPTO/PPA-XX.XXX.XXX.XXX-
20200716172803126739-8885
2845-740cd62bc70b5ff5b3d1
822927b4c98060511eb6a0be5
89e5fb4997706b7f1-N/A-N/A
-20200716172354854345



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1771 (Rev 10/2011)
OMB No. 0651-0050 (Exp 09/20/2020)

Post-Approval/Publication/Post-Notice of Allowance (NOA) Amendment


To the Commissioner for Trademarks:

Application serial no. 88852845 DAXXIFY(Standard Characters, see http://uspto.report/TM/88852845/mark.png) has been amended as follows:

EXPLANATION OF FILING
A typographical error was made in the applicant?s name when the application was filed, specifically, the period at the end of ?Inc? is missing. The applicant?s correct name is ?Revance Therapeutics, Inc.? This error occurred in good faith.

OWNER AND/OR ENTITY INFORMATION
Applicant proposes to amend the following:
Current: Revance Therapeutics, Inc, a corporation of Delaware, having an address of
      7555 Gateway Blvd.
      Newark, California 94560
      United States
      Email Address: XXXX

Proposed: Revance Therapeutics, Inc., a corporation of Delaware, having an address of
      7555 Gateway Blvd.
      Newark, California 94560
      United States
      Email Address: XXXX
Correspondence Information (current):
      MAREN C. PERRY
      PRIMARY EMAIL FOR CORRESPONDENCE: nytrademarks@kslaw.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): mperry@kslaw.com

The docket/reference number is 13720.104073.
Correspondence Information (proposed):
      Maren C. Perry
      PRIMARY EMAIL FOR CORRESPONDENCE: nytrademarks@kslaw.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): mperry@kslaw.com

The docket/reference number is 13720.104073.

Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).

SIGNATURE(S)

Signature: /mcp/     Date: 07/16/2020
Signatory's Name: Maren C. Perry
Signatory's Position: Attorney of Record, New York Bar member

Signatory's Phone Number: (212) 556-2128

The signatory has confirmed that he/she is a U.S.-licensed attorney who is an active member in good standing of the bar of the highest court of a U.S. state (including the District of Columbia and any U.S. Commonwealth or territory); and he/she is currently the owner's/holder's attorney or an associate thereof; and to the best of his/her knowledge, if prior to his/her appointment another U.S.-licensed attorney not currently associated with his/her company/firm previously represented the owner/holder in this matter: the owner/holder has revoked their power of attorney by a signed revocation or substitute power of attorney with the USPTO; the USPTO has granted that attorney's withdrawal request; the owner/holder has filed a power of attorney appointing him/her in this matter; or the owner's/holder's appointed U.S.-licensed attorney has filed a power of attorney appointing him/her as an associate attorney in this matter.

Mailing Address:    MAREN C. PERRY
   KING & SPALDING LLP
   
   1185 AVENUE OF THE AMERICAS
   NEW YORK, New York 10036
Mailing Address:    Maren C. Perry
   KING & SPALDING LLP
   1185 AVENUE OF THE AMERICAS
   NEW YORK, New York 10036
        
Serial Number: 88852845
Internet Transmission Date: Thu Jul 16 17:28:03 ET 2020
TEAS Stamp: USPTO/PPA-XX.XXX.XXX.XXX-202007161728031
26739-88852845-740cd62bc70b5ff5b3d182292
7b4c98060511eb6a0be589e5fb4997706b7f1-N/
A-N/A-20200716172354854345



uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed